CELZ Creative Medical Technology Holdings, Inc. logo

CELZ Creative Medical Technology Holdings, Inc.

Healthcare
$2.39+3.04%ClosedMarket Cap: $6.2M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

1.45

P/S

2055.92

EV/EBITDA

-0.08

DCF Value

$2.95

FCF Yield

-90.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

-3986.6%

Operating Margin

-198049.6%

Net Margin

-192066.3%

ROE

-88.5%

ROA

-89.5%

ROIC

-96.9%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$0.00$-1.4M$
Q4 null$3.0K$-1.9M$
FY null$6.0K$-6.0M$
Q3 null$0.00$-1.2M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Finger Michael H.director
SellThu Feb 20
Warbington Timothydirector, officer: President & CEO
BuyThu Jun 29
Warbington Timothydirector, officer: President & CEO
BuyThu Jun 29
Warbington Timothydirector: President & CEO
BuyWed Nov 23
Warbington Timothydirector: President & CEO
BuyWed Nov 23

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

Beta

1.85

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Peers